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Quantitative histopathologic assessment of perfusion MRI as a marker of 
glioblastoma cell infiltration in and beyond the peritumoral edema region 
ABSTRACT 
Background: Conventional MRI fails to detect regions of glioblastoma cell infiltration 
beyond the contrast-enhanced T1 solid tumor region, with infiltrating tumor cells often 
migrating along host blood vessels. 
Purpose: To quantitatively and qualitatively analyze the correlation between perfusion MRI 
signal and tumor cell density in order to assess whether local perfusion perturbation could 
provide a useful biomarker of glioblastoma cell infiltration. 
Study Type: Animal model 
Subjects: Mice bearing orthotopic glioblastoma xenografts generated from a patient-derived 
glioblastoma cell line. 
Field Strength/sequences:  7T perfusion images acquired using a high SNR multiple boli 
arterial spin labeling sequence were compared with conventional MRI (T1/T2 weighted, 
contrast-enhanced T1, diffusion-weighted and apparent diffusion coefficient). 
Assessment:  Immunohistochemistry sections were stained for human leukocyte antigen 
(probing human-derived tumor cells). To achieve quantitative MRI-tissue comparison, 
multiple histological slices cut in the MRI plane were stacked to produce tumor cell density 
maps acting as ‘ground truth’. 
Statistical Tests:  Sensitivity, specificity, accuracy and Dice similarity indices were 
calculated and a two tailed, paired t-test used for statistical analysis. 
Results: High comparison test results (Dice 0.62-0.72, Accuracy 0.86-0.88, Sensitivity 0.51-
0.7, and Specificity 0.92-0.97) indicate a good segmentation for all imaging modalities and 
highlight the quality of the MRI-tissue assessment protocol. Perfusion imaging exhibits 
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higher sensitivity (0.7) than conventional MRI (0.51-0.61). MRI/histology voxel-to-voxel 
comparison reveals a negative correlation between tumor cell infiltration and perfusion at the 
tumor margins (p=0.0004).  
Data Conclusions: These results demonstrate the ability of perfusion imaging to probe 
regions of low tumor cell infiltration while confirming the sensitivity limitations of 
conventional imaging modalities. The quantitative relationship between tumor cell density 
and perfusion identified in and beyond the edematous T2 hyper-intensity region surrounding 
macroscopic tumor could be used to detect marginal tumor cell infiltration with greater 
accuracy. 
Level of Evidence 1 
Technical stage: 2 
Keywords 
mbASL, perfusion, multiparametric MRI, glioblastoma, tumor infiltration, mouse   
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INTRODUCTION 
Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Survival in 
patients receiving the current standard of care is less than a year after diagnosis(1). A major 
factor contributing to treatment failure is the ability of tumor cells to infiltrate normal brain 
regions(2), extending several centimeters from the tumor bulk edge. Infiltration compromises 
the ability to achieve complete surgical resection of the tumor, thereby contributing to high 
recurrence rates, and limitations in the ability to accurately image infiltration reduce the 
accuracy of target volume delineation for radiotherapy planning(3). It is crucial to develop 
imaging modalities that enable better tumor delineation; particularly when considering 
marginal regions with low tumor cell density. 
Despite providing rich insights into tumor characteristics, conventional clinical MRI methods 
such as contrast-agent enhanced T1 (cT1), T2 weighted (T2), diffusion weighted (DW) or 
apparent diffusion coefficient maps (ADC), fail to characterize regions of low density tumor 
cell infiltration. cT1 images allow delineation of strongly enhancing regions corresponding to 
solid tumor with pathologic neovascularization(4), often surrounding a non-enhancing 
necrotic core. T2 imaging commonly reveals extensive regions of abnormality surrounding 
the cT1 enhancing lesion. While these regions are associated with edema, several biopsy 
studies have demonstrated the presence of infiltrating tumor cells within them(5), with the 
extent of the hyper-intensity region being inversely correlated with survival(6). Evaluating 
progression of T2 to cT1 abnormalities (7) suggests that high T2 signal regions could 
represent an earlier stage of tumor development. However, beyond the cT1 enhancement 
region, there is currently no reliable method for probing the extent and density of tumor cell 
infiltration. Accurate delineation is often compromised by MRI sensitivity limitations related 
to the fact that marginal tumor cell density is much lower than healthy tissue cellular density.  
5 
 
Several approaches for probing regions of low tumor cell density are currently under 
investigation. Infiltration of white matter tracts has been extensively characterized by DTI, 
with fractional anisotropy properties being related to infiltration patterns (8). MR 
spectroscopy focusing on increased choline peaks (9) has probed the hyper-metabolic 
behavior of tumor cells in the vicinity of the cT1 enhancement region. Perfusion 
measurements in the same region tend to show increased values due to early angiogenesis 
(10). Despite some promising results, most of these approaches suffer from sensitivity 
limitations restricting their use to regions of higher tumor cell density, typically adjacent to 
the cT1 abnormal region. However, theoretical invasion models accounting for MRI 
sensitivity suggest that infiltration may often extend beyond abnormal T2 regions (11). 
Distant from the cT1 enhancement region, invading tumor cells often progress along blood 
vessels and in the absence of angiogenesis, co-option(12) tends to be the predominant 
mechanism by which they access blood supply. Published data indicate that even individual 
cells can disrupt blood-brain barrier (BBB) integrity (13), thus providing an opportunity to 
detect tumor infiltration at its earliest stages. Perfusion MRI measurements performed either 
with the use of contrast agents or by arterial spin labeling (ASL) (14) could allow probing of 
such effects. Perfusion MRI is already used to improve GBM delineation and facilitate 
clinical decision making(15). Contrast-enhanced techniques such as dynamic susceptibility 
contrast (DSC) and dynamic contrast enhancement (DCE) are widely used in brain tumor 
imaging (16), but their relatively low signal to noise ratio (SNR) in infiltrated healthy tissue 
regions makes subtle perfusion perturbation studies challenging. ASL is non-invasive and has 
been shown to provide similar results to DSC in brain tumor studies, with fewer susceptibility 
artefacts (14). If sufficient SNR could be achieved, this technique, which uses blood water as 
a marker of perfusion, could be more sensitive to subtle perfusion perturbations in the 
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infiltration zone than other methods, making it a suitable candidate for probing infiltration 
away from the cT1 enhancement region.  
Robustly assessing the ability of MRI protocols to probe tumor infiltration is another 
important challenge. Clinical studies using stereotactic biopsy techniques are limited to 
measurements within regions of T2 abnormality, relying on MRI for accurate sampling and 
typically suffering from low precision(17). Preclinical studies provide an opportunity for 
more quantitative histopathologic MRI assessment; however, most studies to date have used 
qualitative approaches, probably due to difficulties with MRI/histology registration(18). 
Often, histological slices are not cut in the MRI plane and the enormous difference in slice 
thickness compared with MRI is ignored (histology~20 m, MRI~1000 m). The 
development of new methods for quantitative histopathologic assessment of MRI modalities 
is crucial in order to analyse infiltrative glioblastoma models where heterogeneous tumor 
distributions can vary considerably within the MRI slice thickness.  
This study aims to quantitatively and qualitatively analyze the correlation between perfusion 
MRI signal and tumor cell density at the tumour margins, to assess whether local perfusion 
perturbation could provide a useful biomarker of glioblastoma cell infiltration in and beyond 
the peritumoral edema region. 
Materials and Methods 
Tumor model and experimental design 
Experiments were performed on CD1 nude mice (Charles River Laboratories), in accordance 
with the local ethical review panel (19). Mice (20-25 g) were acclimatized at least one week 
prior to any experimental procedure. G7 human glioblastoma cells were cultured in stem-like 
conditions (Advanced DMEM:F12, containing 20M EGF/FGF, 1% B27, 0.5% N2, heparin, 
1% L-Glut) on Matrigel coated plates. The animals were intracranially injected with G7 cells 
7 
 
(105 cells per mouse) into the sub-ventricular zone using stereotactic equipment(20). Study 
outcomes are reported following the ARRIVE guidelines(21). 
Ten animals were scanned 9 and 12 weeks after GBM cell injection. Following MRI, animals 
were sacrificed and brains were freeze-fixed to minimize macroscopic tissue 
deformation(22). MRI assessment was performed using 3D datasets of registered MRI with 
Human Leukocyte Antigen density maps achieved by averaging multiple histological slices 
evenly distributed in the MRI plane.  
Four additional animals were scanned at weeks 12 and 15 to allow the formation of a necrotic 
core. Following MRI, the animals were sacrificed and brains were paraffin embedded to 
minimize microscopic deformation of cells to allow high-resolution histology analysis. 
MRI set up and acquisition 
MRI experiments were performed on a Bruker Biospec Avance 7T imaging system with a 30 
cm horizontal bore (Bruker, Ettlingen, Germany). Homogeneous radiofrequency excitation 
was achieved using a birdcage volume resonator (diameter=72 mm, length=110 mm) and an 
actively decoupled 4-channel phased array receive-only head surface coil was used for signal 
detection (Rapid Biomedical, Wurzburg, Germany). The system was equipped with shielded 
magnetic field gradients producing up to 400 mT m-1.  
The animals were anaesthetized using 5% isoflurane and a 30:70 O2/N2O ratio before being 
positioned prone on a MRI animal cradle. A hot water circulation jacket was used to regulate 
physiological temperature (37±1 oC). The head was secured laterally by conical ear rods and 
longitudinally by the nose cone used for anesthetic gas delivery. The animals breathed 
spontaneously through a facemask, with isoflurane delivered at a constant flow mixed with a 
40:60 ratio of O2/N2O (1 L min
-1). Isoflurane concentration varied (1.5-3 %) in order to 
maintain stable respiration rates within normal physiological ranges (40-70 bpm). Respiration 
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was monitored using a pressure sensor connected to an air-filled balloon placed under the 
animal abdomen (Biotrig software, Bruker, Ettlingen, Germany). 
Following a geometry-correction sequence, a series of MRI experiments were performed 
(field of view 2×2 cm, five 1.5 mm coronal imaging slices centered at 4 mm posterior from 
rhinal fissure). T2-weighted imaging (T2) was performed using a rapid acquisition with 
relaxation enhancement (RARE) sequence (TE=47 ms, TR=4,300 ms, matrix=176×176, 9 
min). Higher resolution T2 images (slice thickness=0.5 mm) were acquired during the final 
scanning session. Diffusion-weighted imaging (DW) was performed using a 4-shot spin-echo 
planar imaging DW scan (TE=20 ms, TR=4,300 ms, matrix=128×128, 6 directions, b-
values= 0, 1000 s mm-2, 10 min). Perfusion weighted imaging (PW) was performed using an 
optimized multiple boli Arterial Spin Labeling sequence (mbASL)(23), labeling with a train 
of twenty hyperbolic-secant inversion pulses (duration=3.3 ms, dimensionless amplitude 
parameter 𝜇=8, angular modulation 𝛽=760 s-1) evenly distributed over 5 s  (post-labeling 
delay=50 ms). The inversion slice width was 8.5 mm and the offset from the imaging slice 
was 15 mm. Image acquisition was achieved with an 4-shot EPI module (TE=12 ms, TR=7 s, 
matrix=96×96, partial FT=1.4, 12 averages, 9 min). Finally, contrast-enhanced T1 imaging 
(cT1) was performed using RARE acquisition (TE=12.3 ms, TR=800 ms, matrix=176×176, 8 
min). Images were acquired before and 5 min after Gadolinium-DTPA injection. Following 
animal scanning, MRI experiments were repeated on a doped water phantom used for 
correcting receiver coil bias. Data were exported in DICOM format. 
Histology protocols 
Freeze-fixation 
Following MRI, anaesthetized mice received an intravenous injection of 0.1 ml 7.5 mg ml-1 
70kDa Texas red labeled dextran (Thermo Fisher Scientific, UK) in PBS, for subsequent 
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brain perfusion analysis. Two minutes following injection mice were sacrificed and brains 
were removed and fresh-frozen. Brain slicing was performed manually on an OTF 5000 
Bright cryostat, guided by high-resolution T2 images. The identification of common features 
by an experienced neuroscience research technician (L.G. 20 years experience) allowed 
positioning the sectioning plane parallel to the MRI plane. Interleaved 20 m and 60 m 
sections were cut. The 20 μm cryosections were fixed in ice-cold acetone and washed in PBS 
before blocking in 3% BSA/TBS/0.05% tween for 30 mins at room temperature. A 1:500 
dilution HLA antibody (abcam ab70328) in blocking buffer was added and incubated for 2 
hours at room temperature. Sections were washed three times with TBS-Tween before 
addition of 1:1000 anti-mouse Alexa 647-conjugated secondary antibody (A-21236, Thermo 
Fisher Scientific, UK) for 1 hour incubation in the dark. Sections were washed 3 times with 
TBS-Tween and mounted in ProLong Diamond Antifade mount with DAPI (P36966, Thermo 
Fisher Scientific, UK). Whole brain section tile scans were conducted using a Zeiss 710 
upright confocal microscope. For dextran imaging, unfixed 60 μm cryosections were imaged 
by z-stack tile scanning on a Zeiss 710 upright confocal microscope. Images were exported as 
.tiff.  
Paraffin embedding 
Mice were sacrificed and brains dissected, cut in half through tumor injection site, formalin-
fixed, paraffin-embedded and sectioned (4 µm). Sections were stained for  hematoxylin and 
eosin (H&E), Ki67, or incubated with 1:500 dilution HLA antibody (abcam ab70328) and 
visualised using DAB staining (Dako EnVision + System HRP (DAB) K4007) followed by 
counterstaining and mounting. Sections were imaged using a Hamamatsu Nanozoomer Slide 
scanner with Leica SlidePath imaging Software (J.B. 8 years experience) or tiling at x10 on a 
Zeiss Axio microscope. 
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Image and data analysis 
Figure 1 summarizes the protocol for the production of 3D datasets used for MRI assessment. 
The most critical steps are highlighted in SuppFig1. Data were processed using Matlab 
R2015a (MathWorks Ltd., U.K.) code developed in-house. 
***Fig. 1 appears near here*** 
 
Figure 1. Simplified diagram of the pipeline leading to the production of 3D matrices combining MRI 
and histology data. Quantitative evaluation of MRI segmentation was achieved by comparing MRI 
and tumor cell density maps from the resulting dataset. 
MRI 
Surface-coil sensitivity correction was performed on T2 and DW data by dividing by the 
phantom data(24). Normalized relative perfusion maps (PW) were achieved by subtracting 
the control and label images acquired with different states of arterial blood magnetization, 
and dividing by the control(25), (Mcontrol - Mlabel ) / Mcontrol. Contrast enhanced images (cT1) 
were achieved by subtracting T1 acquisitions before and after Gd injection, and normalizing 
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by T1 data acquired before injection, (MpostGd – MpreGd ) / MpreGd. ADC maps were calculated 
by fitting the data to the mono-exponential Stejkal-Tanner equation. All data were resized to 
T2 resolution (176×176) and a mask was applied to null extra-brain regions. 
Histology 
Histology slice images exported from fluorescence microscopy were registered, resized to 
MRI data and normalized using the RGB histogram method. Three to five slices (inter-slice 
distance~0.3 mm) distributed across the MRI slice were averaged to produce tumor cell 
density maps (TCD), where signal intensity is proportional to the intra-voxel concentration of 
tumor cell cytoplasm. MRI-TCD registration was performed using an affine intensity-based 
scheme (mutual information method).  
Image segmentation  
Tumor-related abnormal regions of interest (ROI) probed by each imaging modality were 
manually drawn by H.F.I.A. and A.V. (3 and 5 years experience respectively) in the region 
where the TCD map was produced. PW segmentation was facilitated by comparison with 
healthy mice PW images (SuppFig.2). MRI ROI delineation was performed without prior 
knowledge of the histology data, to avoid selection bias. Care was taken not to include non-
invasion related enhancement (e.g. ventricle compression). Animals that did not exhibit 
tumor growth (n=1) were removed from the study while animals with necrotic lesions were 
not considered for voxel-to-voxel comparison with TCD maps (n=2). Histology ROIs were 
selected on the basis of HLA stain intensity on TCD maps. To minimise HLA staining 
artefacts, manual selection was favored to a user-independent intensity-based selection. 
Clustering separating high and low tumor density regions within TCD ROIs (A.V. ROI 
selection) was performed  using a gaussian mixture model(26). 
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Statistical analysis 
TCD ROIs were considered as the “ground truth” for evaluating MRI ROIs. Interobserver 
reproducibility was quantified using the coefficient of variation (CV), calculated for each 
lesion by 100×standard deviation/mean, and averaged for each imaging modality. Sensitivity, 
specificity, accuracy and Dice similarity indices (27,28) were calculated for each animal and 
imaging modality. Two tailed student t-test was used for comparisons between MRI tumor 
regions and histology tumor region. All values are reported as mean ± standard deviation. 
Box plots show the mean (black line), median (blue line), 25th/75th percentiles (box) and 
extreme points (whiskers) not considered outliers (within 1.5 times the interquartile range). 
Raw data (red dots) are jittered along x. Statistical significance flags: * p<0.05, ** p<0.01, 
*** p<0.001, **** p<0.0001 and NS not statistically significant. 
RESULTS 
A marginal infiltration model 
Figure 2A shows T2 and cT1 images obtained from the same animal at 12 and 15 weeks post-
injection. At week 15 all cT1 images presented a non-enhancing necrotic core surrounded by 
a contrast-enhancing region identified as solid tumor. Regions of abnormal T2 signal were 
systematically larger than cT1, with the mismatch often identified as low density tumor cell 
infiltration in the healthy tissue (Figure 2B(ii)). Figure 2C shows T2 and cT1 images obtained 
from three animals at 12 weeks post-injection. While significant abnormal volumes are 
visible on T2, most cT1 showed no significant signal change. Only three cases of minor cT1 
contrast enhancement in the brain region were identified at week 12 (e.g. Figure 2C(iii)) and 
necrotic cores were either very small or invisible. Note that at these earlier time points, T2 
abnormalities appeared more homogeneous and were of similar volume amongst animals 
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(SuppFig.3A-C), while after week 12, tumor growth varied significantly between animals and 
weight loss was observed in some (SuppFig.3C-D).    
***Fig. 2 appears near here*** 
 
Figure 2. (A) T2 weighted and contrast enhanced T1 images at 12 (i) and 15 (ii) weeks post-injection 
for the same animal. (B) Ki67 immunohistochemistry on slices obtained from the animal shown in 
(B), within the MRI image plane and 0.8 mm apart (magnification ×10). Regions of necrosis (i) and 
infiltration (ii) are highlighted. (C) T2 weighted and contrast enhanced T1 images obtained 12 weeks 
post-injection. 
PW detects more extensive regions of tumor infiltration than conventional MRI 
Representative images obtained at weeks 9 and 12 during the longitudinal MRI study are 
shown in Figure 3A-B.  Most techniques detected a tumor related region of abnormality by 
week 9. Tumor-related lesions remained homogeneous until week 12 and appeared as hyper-
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intense on T1, T2 and DW and hypo-intense on ADC and PW. Only two cases exhibited 
small necrotic cores at this stage of tumor progression (high ADC in the tumor core). FA 
values were low in tumor core regions, characteristic of both edema and isotropic tumor 
proliferation, and high in tumor margin regions. At week 12, strong similarity was observed 
between the abnormal regions identified by the different MRI modalities and the regions of 
high tumor cell concentration identified on tumor cell concentration maps (TCD). SuppFig.4 
shows the corresponding MRI ROIs. Interobserver CV at week 9 was of 29% for T2, 12% for 
DWI and 19% for ADC and PW. At week 12, CV was of 20% for T1 and T2, 21% for DWI, 
19% for ADC, 12% for PW and 10% for TCD maps.  
 
***Fig. 3 appears near here*** 
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Figure 3. Images from different MRI modalities at weeks 9 (A) and 12 (B) post-injection. cT1 values 
were not included since only 3 mice exhibited cT1 enhancement at this stage. Week 12 also includes 
the tumor cell density map (TCD) obtained for the same brain region. The displayed PW contrast was 
adjusted to allow clearer differentiation within the invasion area. Tumor related abnormal volumes 
measured 9 weeks (C) and 12 weeks (D) post injection (n = 9). 
 
Figure 3 C-D show the average volumes of tumor related abnormal regions for each imaging 
modality (including tumor cell density maps) at 9 and 12 weeks post-injection of G7 cells. At 
both time points, PW imaging exhibited significantly larger abnormal regions than relaxation 
(T1, T2) or diffusion (DW, ADC) based MRI techniques. For week 9, the results have to be 
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considered cautiously, as the lesions are relatively small and the resizing of lower resolution 
imaging modalities (e.g. PW) can introduce increases of the abnormality-related ROI. 
Considering a Gaussian infiltration front (SuppFig.5), the resulting ROI error was estimated 
at about 10% for the smaller lesions of this work (week 9) and below 1% for medium and 
large lesions (week 12). Note that this error is small compared to the T2/PW abnormal 
volume ratio (~60% on week 9 and ~75% on week 12). 
The 3D matrices allow a quantitative evaluation of MRI techniques in comparison with the 
‘ground truth’ provided by the TCD maps. While no significant difference between PW 
abnormal volumes and TCD volumes was observed (p=0.2), abnormal volumes detected by 
all other imaging techniques were significantly smaller. Figure 4 shows the results of various 
segmentation evaluation tests applied to the volume calculation ROIs.  
***Fig. 4 appears near here*** 
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Figure 4. Dice score (A), accuracy index (B), sensitivity index (C) and specificity index (D) achieved 
for the segmentation of each imaging modality at week 12, in comparison with TCD segmentation 
(“ground truth”). ROIs were the same as for the volume analysis shown in  Figure 3. 
All segmentations achieved relatively high Dice scores and accuracy indices (27) (Figure 4A-
B), highlighting the quality of the quantitative histological evaluation protocol. While PW 
segmentation achieved the highest Dice score, with T2 and ADC providing with the best 
results amongst standard MRI protocols, Dice score differences did not reach statistical 
significance (p=0.2 for t-test comparison between PW and T2 Dice score distributions). 
However, PW was associated with significantly higher sensitivity than other techniques 
(Figure 4C). Conversely, relaxation and diffusion based imaging showed higher specificity 
than perfusion (Figure 4D). This reflects firstly the fact that standard MRI protocols under-
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evaluate tumor volume and secondly that, while average PW ROI volume (15±3 mm3) was 
similar to the average TCD ROI volume (16±2 mm3), in three cases PW ROI volumes were 
found to be greater than TCD ones (by 13%, 8% and 3%).   
A relationship between perfusion and invasion in tumor margin regions 
Histological analysis was performed to better characterize the relationship between perfusion 
and tumor cell infiltration. Figure 5A shows a comparison between histological slices probing 
the perfusion/delivery of FITC-dextran 70kDa and slices from the same animal stained for 
HLA, in the same region as the MRI images shown in Figure 3A-B.  As expected, there is a 
strong relationship between PW imaging and FITC-dextran staining, with regions of hypo-
perfusion clearly demarcated by both techniques. Regions of increased tumor cell density 
exhibited reduced perfusion in both PW and dextran assays; this was also highlighted by the 
similarity test results comparing TCD ROI with PW ROI (Figure 4A-B).  
This relationship between perfusion and infiltration was stronger in marginal regions of lower 
tumor cell density. This is highlighted by the dataset from one mouse that developed two 
distinct tumor lesions (Figure 5B): a high density lesion (near the tumor cell injection point) 
surrounding a small necrotic core (white spots on T2 and ADC; black spots on HLA) and a 
more homogeneous, low tumor density lesion that appeared later in tumor development. The 
physical connection between the two lesions, occurring at the back of the brain, is indicated 
by the red arrows on the T2 images shown in Figure 5B(ii). While both PW and dextran 
images show a reduction in perfusion in the newly infiltrated lower region, the relation 
between dextran delivery and invasion is less clear around the necrotic core of the main 
lesion.  
Histological analysis of formalin-fixed tissue allows better understanding of the cellular 
mechanisms underlying the relationship between marginal tumor infiltration and perfusion. 
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Figure 5C-D shows histological images derived from a G7 tumor edges. The combination of 
H&E and tumor cell specific HLA staining revealed that several blood vessels at the tumor 
margins were surrounded by tumor cells. In some cases, vascular cuffing by invading tumor 
cells was observed at locations remote from the tumor front (Figure 5D). 
 
***Fig. 5 appears near here*** 
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Figure 5. (A) Fluorescence microscopy images probing HLA and dextran 70kDa at two different 
locations within the MRI slices shown in Figure 3B (magnification ×10). (B) (i) MRI (T2, ADC, PW) 
and fluorescence microscopy images (HLA, dextran) from a mouse at 12 weeks post injection (ii) T2 
images of thickness 0.5 mm acquired at the same time point. The red doted box highlights the three 
0.5 mm thick T2 slices acquired at the same location as the T2 image shown in Figure B(i). The red 
arrows show connection points between the upper and the lower tumor lesion. (C-D). Tumor margin 
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samples of brains stained for H&E and HLA. Regions of vascular cuffing by invading tumor cells are 
enlarged.  
Perfusion variation as a marker of tumor cell infiltration 
The high values of the segmentation evaluation indices (Figure 4) indicate good agreement 
between MRI and histology datasets, enabling voxel-to-voxel comparison between MRI 
modalities and TCD maps to be undertaken. PW and TCD images for each animal (Figure 
6A) were used to produce scatter plots of perfusion against tumor cell density (Figure 6B). 
Tumor positive voxels on TCD maps that corresponded to manually defined ROI on PW 
images are highlighted (red points). At the interface between healthy brain and tumor 
infiltration regions, voxels of extremely low tumor cell density exhibit similar PW values to 
voxels that are outside the tumor infiltration regions. As suggested by the histology data 
analysis (Figure 5), perfusion was generally high in low TCD value voxels, and decreased 
with increasing TCD.  This indicated that the voxel-to-voxel approach could be applied to 
further characterize the relationship between perfusion and invasion at the tumor margins. 
This was achieved by comparing high TCD ‘tumor core’ regions, typically situated around 
the G7 cell injection point, with low TCD ‘tumor margin’ regions. To separate these regions, 
clustering analysis was performed on the tumor positive regions of the TCD maps (Figure 
6A).  By focusing on the tumor region and plotting TCD against PW intensity for each voxel 
(Figure 6C), we generated a semi-quantitative representation of the relationship between 
tumor burden, as quantified by TDC, and local perfusion. On this graph, marginal voxels 
(green) exhibit significantly lower average TCD values than core voxels (pink). Importantly, 
these marginal voxels exhibit significantly higher perfusion values than core voxels (Figure 
6D). The relation between perfusion and invasion at the margins was quantified by applying 
separate linear regression fits to the ‘core’ and the ‘margin’ voxel data sets (Figure 6C). A 
significant negative correlation between tumor infiltration and perfusion was observed at the 
tumor margins (where tumor cell infiltration of the normal brain occurs) while no clear 
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relationship was identified in tumor core regions (Figure 6E). Consistent with this, linear 
regression R2 values were significantly higher for margin datasets (Figure 6F). 
***Fig. 6 appears near here*** 
 
Figure 6.(A) T2, PW and TCD images from a single animal. TCD ROI selection in red indicates the 
manually segmented tumor positive region of the brain. Clustering of high and low TCD values was 
used to separate core and marginal tumor regions. (B) Scatter plots of PW signal against TCD for 
each voxel in the images shown in (A);  red points correspond to voxels situated within the TCD ROI 
tumor positive region. (D) Scatter plots of PW signal against TCD for the tumor positive voxels only. 
Linear regression fits were applied separately on data from the core and marginal tumor regions 
obtained by the tumor region clustering shown in (A). “Core” and “margin” region box plots show the 
average PW signal (F), linear regression fit slope (E) and R2 of the fit (G) (n=7).  
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DISCUSSION 
This study has demonstrated the existence of an MRI-detectable relationship between tumor 
cell infiltration and local perfusion in tumor margin regions of an orthotopic glioblastoma 
model that recapitulates imaging and histopathological features of the human disease. To 
achieve this, we interrogated our in vivo model, which exhibits infiltrative tumor margins, 
using a high SNR ASL sequence and a novel MRI validation approach based on the use of 
multiple histology slices in the MRI plane. 
Great care was taken in confirming the clinical relevance of the G7 marginal tumor 
infiltration model. Firstly, this highly infiltrative model exhibits sizeable regions of low 
tumor cell density that are not probed by cT1 and which extend into and beyond the regions 
of abnormal T2 signal. In addition, the relatively slow rate of progression of the G7 model 
enables considerable cell infiltration to take place, recapitulating the clinical scenario where 
edema/infiltration T2 lesions are systematically larger than cT1 lesions. By contrast, 
frequently reported GBM models, where tumor cells poorly infiltrate the depth of the brain 
tissue, exhibit a sharp transition between tumor bulk and healthy brain regions, resulting in 
similar sized T2 and cT1 lesions (18). Without infiltration, tumor growth resembles that of 
cells injected in avascular spaces, where the lack of host blood vessels is associated with 
angiogenesis at very early stages in tumor development (29). As a consequence, these poorly 
infiltrative models tend not to reproduce the clinically observed difference between cT1 and 
T2 growth patterns (30).  
Reproducing a realistic marginal invasion microenvironment is another important challenge. 
In the clinical context, marginal infiltration typically occurs outside contrast enhancing 
regions, in a quasi-normoxic micro-environment. Perfusion drops with increasing distance 
from the contrast-enhancing part of the tumor partly due to limited angiogenesis (31). The 
vascular endothelial growth factor (VEGF) secreted by GBM cells appears to be involved not 
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only in neovascularization but also in edema production(32) through the induction of vascular 
permeability(33). Distant from the hypoxic micro-environment of the tumor core, brain 
tumors may develop and grow using vascular co-option as the main mechanism of neo-
vascularisation(33), without needing an angiogenic switch(34,35). Such co-option 
mechanisms, widely documented in clinical specimens, and have been shown to compromise 
the efficacy of treatments that either target angiogenesis (36) or promote vascular 
normalization or integrity (37) in both primary and metastatic tumors. Consistent with the 
clinical context, G7 tumor cells have been shown to express VEGF both in vivo and in 
vitro(20), hence angiopoiesis is expected close to the tumor core. Here, investigating at 
earlier stages of tumor development allowed to minimize effects related to tumor 
angiogenesis or necrosis. Decreased perfusion in tumor regions is commonly observed in 
rodent glioblastoma models and can be explained by the early stage of tumor progression, 
before contrast-enhancement related to leaky vessels that arise from angiogenesis. In fact, 
newly formed tumor vessels are often non-functional, displaying low blood flow or not 
participating in the microcirculation (31,32). Functional angiogenesis requires solid tumor 
conditions (e.g. significant tumor burden, hypoxia), that can be observed either in non-
infiltrative models that lack clinical relevance, or when the tumors reach such large sizes that 
animal survival and welfare is compromised. Infiltrative preclinical models typically exhibit a 
detectable reduction in perfusion within the tumor lesion(18). The infiltrative nature of the 
G7 model simultaneously ensures reliance on intact host blood vessels (34) and delays 
development of hypoxic tumor core conditions that induce angiogenesis, thus allowing 
accurate modeling of the invasive border of GBM.  
Despite the clear relationship between tumor cell density and perfusion shown in this work, a 
direct connection cannot be assumed and several potential mechanisms should be considered. 
Compression of the peritumoral tissue caused by edema in conjunction with increased 
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intracranial pressure (ICP) is a known cause of reduced local perfusion with increasing 
distance from the contrast-enhancing part of the tumor (31). ICP effects are expected to be 
minimal in this marginal infiltration model due to the relatively small tumor volumes. On the 
other hand, infiltrated tumor burden could cause healthy tissue compression leading to 
perfusion drop. Of note, both tumor infiltration and the observed reduction in perfusion 
extend beyond the detectable T2 lesion. Finally, infiltration along vascular pathways, as seen 
in the G7 model, can affect perfusion by both co-option mechanisms and VEGF vascular 
fenestration effects as discussed earlier. These potential underlying causes of the observed 
relationship will be explored in future studies. 
Marginal glioblastoma infiltration is difficult to probe and evaluate. It challenges MRI 
sensitivity limits and often exhibits inhomogeneous spatial distributions that compromise 
conventional histological validation approaches. In this study, the latter challenge was 
addressed by developing a method for quantitative MRI assessment using a stack of in-plane 
histology slices. This method allowed the quantitative evaluation of a range of MRI 
techniques. T2 sensitivity limits were highlighted, with abnormal T2 signal shown to 
significantly under-evaluate tumor infiltration. The high specificity of T2 in comparison with 
TCD maps reveals that most abnormal T2 regions correspond to regions of tumor infiltration. 
This relationship between high T2 signal and invasion is in agreement with clinical findings, 
both with histological data showing high infiltration in the high T2 signal region surrounding 
cT1 enhancement(5) and patient survival analysis showing a negative correlation with 
abnormal T2 volume(35).  
In this marginal infiltration model, perfusion MRI measurements detected larger lesions than 
any other MRI sequence suggesting that perfusion could be used as a marker of low tumor 
cell density regions. However it is important to consider how these findings may be translated 
to clinical management of GBM. Clinical studies involving perfusion MRI tend to focus on 
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regions surrounding cT1 enhancement where higher signal is expected because of 
angiogenesis. This approach minimizes the SNR issues and enables studying biopsy 
compatible regions, but fails to detect marginal infiltration. However studies can be found 
where cerebral blood flow was measured in more remote regions. Li et al.(36) measured a 
negative perfusion gradient at the margins of metastatic lesions that could be related to the 
co-option/edema mechanisms discussed in this work. The significant relationship observed 
between infiltrating tumor burden and perfusion at the margins suggests that probing 
abnormal perfusion gradients far from the cT1 enhancement regions could facilitate the 
characterization of marginal glioblastoma infiltration into healthy tissue. The sensitivity of 
the approach will be strongly dependent on the SNR of the perfusion MRI used. While in 
high SNR perfusion images the perfusion gradient could be used as a direct marker of tumor 
cell infiltration into the healthy tissue, lower SNR perfusion images could still potentially be 
used to produce tumor infiltration probability maps. It is also crucial to consider the impact of 
alternative, clinically relevant causes of local perfusion perturbation, such as radiation 
therapy and surgery, which may limit the applicability of this technique to pre-therapy 
planning. However, the ability of this approach to improve tumor delineation at the initial 
treatment planning stage would be of enormous value, and might lead to better responses to 
first line surgery and radiation therapy. 
This study was, by necessity, subject to certain limitations which we have sought to address, 
both in its design and also through consideration of its potential for clinical translation. First, 
our analysis used a relatively small number of mice, mainly imposed by the time consuming 
data acquisition and histology processing protocols. This was counterbalanced by the 
introduction of a quantitative histopathologic assessment method which enabled collection of 
high quality data from each mouse, and our main findings exhibited robust statistical 
significance. Another limitation relates to differences between tumor and vessel growth 
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between human gliomas and the G7 model in which tumors grow in the brains of 
immunodeficient mice. We contend that immune status is unlikely to have a significant effect 
on the analysis of the relation between local perfusion and tumor burden proposed here. In 
fact, the tumor-related perfusion drop was related to infiltration through the biomechanical 
effect of vascular co-option and/or edema, which are clinically relevant mechanisms. To 
minimize intracranial pressure and vascular compression effects, tumor size was generally 
limited to less than 10% of total brain volume. This also increased the relevance of evaluation 
tests requiring significant difference between tumor volume and brain volume(27). Finally, 
there are MRI specificities in this work that should be emphasized. The combination of a 7T 
instrument with a novel perfusion sequence allowed us to overcome SNR limitations of 
clinical perfusion imaging based on ASL sequences, enabling the study of low perfusion 
regions. This advantage was counterbalanced by the need to use much higher resolution than 
in a clinical context in order to properly resolve the perfusion distribution within the mouse 
brain. Hence, it is important to recognize that alternative perfusion MRI techniques (e.g. 
DSC) could be more efficient in probing infiltration in a clinical context. 
In conclusion, this work identified a negative relationship between tumor cell burden and 
perfusion MRI signal in infiltrative areas of low tumor cell density distant from regions of 
cT1 enhancement. The robust protocol that we developed to assess the performance of a 
range of MRI modalities at the tumor margins constitutes a significant step toward 
quantitative evaluation of the ability of MRI protocols to probe regions of low tumor cell 
density. Our results indicate that the relationship between perfusion gradient and tumor cell 
density has potential as a marker of tumor infiltration. Future work will concentrate on 
assessment of the clinical relevance of these findings. 
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